Phase I trial of subcutaneous interleukin 3 in patients with refractory malignancy: hematological, immunological, and pharmacodynamic findings. (Q40672198)
Jump to navigation
Jump to search
scientific article published on February 1996
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I trial of subcutaneous interleukin 3 in patients with refractory malignancy: hematological, immunological, and pharmacodynamic findings. |
scientific article published on February 1996 |
Statements
Phase I trial of subcutaneous interleukin 3 in patients with refractory malignancy: hematological, immunological, and pharmacodynamic findings (English)
Bukowski RM
Olencki T
Gunn H
McLain D
Budd GT
Sandstrom K
Tuason L
Redovan C
Rayman P
Tubbs R
Resta D
Elson P
1 February 1996